Abstract
The synergistic action of the cytostatic drug cyclophosphamide (CP) and fragmented exogenous DNA causes illness and death in mice (Dolgova et al., 2011–2013). The observed “delayed death” effect was most clearly pronounced when the DNA preparation was administered 18 to 30 h after CP treatment. This time span was termed the “death window.”
It was found that injections of exogenous DNA result in a sustained increase in bone-marrow cell (BMC) apoptosis, which occurs throughout the time of DNA administration (18–30 h). Exogenous DNA, both allogeneic and belonging to various taxa, induces BMC apoptosis. Plasmid DNA has the greatest effect on apoptosis induction. The analysis of reduction and restoration of the BMC subpopulations as the mice progressed to death revealed a virtually complete loss of the 12–20-μm fraction of the cell population (about 3–4% vs. 35–40% in the control), which corresponds to the maximum leukopenia on day 3 after CP treatment. However, the relative number of CD34+ hematopoietic stem cells (HSCs) from day 15 and until the end of the observation constituted 1.2–1.4%, which corresponds to the wild-type range. Comparison of BMC smears from the sternal bone marrow of the CP and CP + DNA groups of mice indicated that the BMC populations isolated from CP + DNA animals lack young committed lymphopoiesis progenitor cells. Moreover, the affected mice had immature blast cell types in their blood, which was never observed in healthy or CP-treated mice. Pathological and morphological analyses show that starting from posttreatment day 9, mice that received CP + DNA preparations displayed pronounced morphological changes in their lungs, liver, pancreas, central and peripheral immune system organs, and brain. Most of the pathological changes observed are consistent with a severe inflammatory response. This suggestion was proven by structural equivalents of functional involution of lymphoid organs, such as the thymus, spleen, and lymph nodes.
We speculate that the death of treated animals resulted from multiple organ dysfunctions caused by accidental involution of lymphoid organs and the systemic inflammatory response syndrome, both associated with injections of fragmented exogenous DNA into experimental animals within the “death window,” which corresponds to the final step in the repair of the majority of CP-induced double-strand breaks.
Similar content being viewed by others
References
Afanas’eva, Yu.I., Kuznetsova, S.L., and Yurina, N.A., Gistologiya, tsitologiya i embriologiya (Histology, Cytology, and Embryology), Moscow: Meditsina, 2004.
Andrews, N.W., Membrane repair and immunological danger, EMBO Rep., 2005, vol. 6, no. 9, pp. 826–830.
Buckley, R.H., Primary immunodeficiency diseases due to defects in lymphocytes, N. Engl. J. Med., 2000, vol. 343, no. 18, pp. 1313–1324.
Coban, C., Koyama, S., Takeshita, F., et al., Molecular and cellular mechanisms of DNA vaccines, Hum. Vaccin., 2008, vol. 4, pp. 453–456.
Cook, R., Wu, C.C., Kang, Y.J., and Han, J., The role of the p38 pathway in adaptive immunity, Cell. Mol. Immunol., 2007, vol. 4, no. 4, pp. 253–259.
Decker, P., Wolburg, H., and Rammensee, H.G., Nucleosomes induce lymphocyte necrosis, Eur. J. Immunol., 2003, vol. 33, no. 7, pp. 1978–1987.
Decker, P., Singh-Jasuja, H., Haager, S., et al., Nucleosome, the main autoantigen in systemic lupus erythematosis, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation, J. Immunol., 2005, vol. 174, no. 6, pp. 3326–3334.
Derbyshire, M.K., Epstein, L.H., Young, C.S.H., et al., Nonhomologous recombination in human cells, Mol. Cell Biol., 1994, vol. 14, no. 1, pp. 156–169.
Dolgova, E.V., Prokopenko, A.V., Nikolin, V.P., et al., Characterization of changes in the number of moderate repeats in the genome of bone marrow cells of experimental mice treated with cyclophosphamide and exogenous human DNA, Russ. J. Genet. Appl. Res., 2013 (in press).
Dolgova, E.V., Proskurina, A.S., Nikolin, V.P., et al., Characterization of temporal parameters of manifestations of the toxic effect of injections of exogenous DNA after pretreatment with the cytostatic cyclophosphamide, Vavilov. Zh. Genet. Selekts., 2011, vol. 15, no. 4, pp. 674–689.
Dolgova, E.V., Nikolin, V.P., Popova, N.A., et al., Internalization of exogenous DNA into internal compartments of murine bone marrow cells, Russ. J. Genet. Appl. Res., 2012, vol. 2, no. 6, pp. 440–452.
Fugmann, S.D., Rag1 and rag2 in V (D) J recombination and transposition, Immunol. Res., 2001, vol. 23, no. 1, pp. 23–39.
De Gregorio, E. and Rappuoli, R., Inside sensors detecting outside pathogens, Nat. Immunol., 2004, vol. 5, no. 11, pp. 1099–1100.
Harty, J.T., Tvinnereim, A.R., and White, D.W., CD8+ T cell effector mechanisms in resistance to infection, Annu. Rev. Immunol., 2000, vol. 18, pp. 275–308.
Ishii, K.J. and Akira, S., Innate immune recognition of, and regulation by, DNA, Trends Immunol., 2006, vol. 27, pp. 525–532.
Kaufmann, S.H. and Schaible, U.E., Antigen presentation and recognition in bacterial infections, Curr. Opin. Immunol., 2005, vol. 17, no. 1, pp. 79–87.
Kotnis, A., Du, L., Liu, C., et al., Non-homologous end joining in class switch recombination: the beginning of the end, Philos. Trans. R. Soc. Lond. B. Biol. Sci., 2009, vol. 364, no. 1517, pp. 653–665.
Krishan, A., Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining, J. Cell Biol., 1975, vol. 66, no. 1, pp. 188–193.
Kruglyakov, P.V., Sokolova, I.B., and Polyntsev, D.G., Stem cells of differentiating tissues of an adult organism, Tsitologiya, 2008, vol. 50, no. 7, pp. 557–567.
Lee, S., Oshige, M., Durant, S.T., et al., The SET domain protein Metnase mediates foreign DNA integration and links integration to nonhomologous end-joining repair, Proc. Natl. Acad. Sci. U.S.A., 2005, vol. 102, no. 50, pp. 18075–18080.
Lees-Miller, S.P. and Meek, K., Repair of DNA double strand breaks by non-homologous end joining, Biochimie, 2003, vol. 85, no. 11, pp. 1161–1173.
Lekstrom-Himes, J.A. and Gallin, J.I., Immunodeficiency diseases caused by defects in phagocytes, N. Engl. J. Med., 2000, vol. 343, no. 23, pp. 1703–1714.
Macgregor, C. and Varley, J., Working with Animal Chromosomes, Chichester: Wiley, 1984.
Martin, D.A. and Elkon, K.B., Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll-like receptor 9-independent pathway, Arthritis Rheum., 2006, vol. 54, pp. 951–962.
Medzhitov, R., Recognition of microorganisms and activation of the immune response, Nature, 2007, vol. 449, no. 7164, pp. 819–826.
Mayle, D., Brostoff, J., Roth, D.B., and Reutte, A., Immunologiya (Immunology), Moscow: Logosfera, 2007.
Merrell, D.S. and Falkow, S., Frontal and stealth attack strategies in microbial pathogenesis, Nature, 2004, vol. 430, no. 6996, pp. 250–256.
Mueller, A. and Falkow, S., Persistent bacterial infections: the interface of the pathogen and the host immune system, Nat. Rev. Microbiol., 2004, vol. 2, no. 9, pp. 747–765.
Napirei, M., Karsunky, H., Zevnik, B., et al., Features of systemic lupus erythematosis in DNase 1-deficient mice, Nat. Genet., 2000, vol. 25, no. 2, pp. 177–181.
Orkin, S.H. and Zon, L.I., Hematopoiesis: an evolving paradigm for stem cell biology, Cell, 2008, vol. 132, no. 4, pp. 631–644.
Proskuryakov, S.Ya., Gavai, V.P., and Konoplyannikov, A.G., Immunology of necrosis and apoptosis, Biochemistry (Moscow), 2005, vol. 70, pp. 1593–1605.
Ravetch, J.V., A full complement of receptors in immune complex diseases, J. Clin. Invest., 2002, vol. 110, no. 12, pp. 1759–1761.
Rosen, F.S., Cooper, M.D., and Wedgwood, R.J., The primary immunodeficiencies, N. Engl. J. Med., 1995, vol. 333, no. 7, pp. 431–440.
Rossi, D.J., Jamieson, C.H., and Weissman, I.L., Stems cells and the pathways to aging and cancer, Cell, 2008, vol. 132, no. 4, pp. 681–696.
Rouse, B.T. and Suvas, S., Regulatory cells and infectious agents: detentes cordiale and contraire, J. Immunol., 2004, vol. 173, no. 4, pp. 2211–2215.
Rykova, E.Yu., Laktionov, P.P., and Vlasov, V.V., The activatory effect of DNA on the immune system, Usp. Sovrem. Biol., 2001, vol. 121, pp. 160–171.
Sambrook, J., Fritsch, E.F., and Maniatis, T., Molecular Cloning, a Laboratory Manual, 2nd ed., Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989.
Shirota, H., Ishii, K.J., Takakuwa, H., and Klinman, D.M., Contribution of interferon-beta to the immune activation induced by double-stranded DNA, Immunology, 2006, vol. 118, pp. 302–310.
Silva, J. and Smith, A., Capturing pluripotency, Cell, 2008, vol. 132, no. 4, pp. 532–536.
Takeshita, F. and Ishii, K.J., Intracellular DNA sensors in immunity, Curr. Opin. Immunol., 2008, vol. 20, pp. 383–388.
Volkova, O.V. and Eletskii, Yu.K., Osnovy gistologii i gistologicheskoi tekhniki (Fundamentals of Histology and Histological Techniques), Moscow: Meditsina, 1971.
Wang, H., Rosidi, B., Perrault, R., et al., DNA ligase III as a candidate component of backup pathways of nonhomologous end joining, Cancer Res., 2005, vol. 65, no. 10, pp. 4020–4030.
Warren, J.S., Yabroff, K.R., Remickd, G., et al., Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat, J. Clin. Invest., 1989, vol. 84, no. 6, pp. 1873–1882.
Whaley, K., Complement and immune complex diseases, in Complement in Health and Disease, Whaley, K., Ed., Lancaster: MTP Press Ltd, 1987.
Yu, J. and Thomson, J.A., Pluripotent stem cell lines, Genes Dev., 2008, vol. 22, no. 15, pp. 1987–1997.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © E.V. Dolgova, V.P. Nikolin, N.A. Popova, A.S. Proskurina, K.E. Orishchenko, E.A. Alyamkina, Ya.R. Efremov, S.I. Baiborodin, E.R. Chernykh, A.A. Ostanin, S.S. Bogachev, T.S. Gvozdeva, E.M. Malkova, O.S. Taranov, V.A. Rogachev, A.S. Panov, S.N. Zagrebelnyi, M.A. Shurdov, 2013, published in Vavilovskii Zhurnal Genetiki i Selektsii, 2013, Vol. 17, No. 1, pp. 129–146.
Rights and permissions
About this article
Cite this article
Dolgova, E.V., Nikolin, V.P., Popova, N.A. et al. Pathological changes in mice treated with cyclophosphamide and exogenous DNA. Russ J Genet Appl Res 3, 291–304 (2013). https://doi.org/10.1134/S2079059713040035
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079059713040035